SCHEMBL30762600

SCHEMBL30762600

CCc1c(C)c(N2CCOCC2)nc2ccc(C)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 3/20 0.51
▸ L3MBTL1 Q9Y468 3/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ ACHE P22303 2/20 0.49
▸ KMT2A Q03164 6/20 0.48
▸ POLB P06746 3/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ ALDH1A1 P00352 8/20 0.45
▸ KDM4E B2RXH2 7/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ NUDT1 P36639 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ HPGD P15428 6/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ HTT P42858 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30762361 0.83 ALDH1A1 (0.49) ATML3MBTL1TDP1ACHEKMT2A
SCHEMBL30762357 0.79 ALDH1A1 (0.52) ATML3MBTL1TDP1ACHEKMT2A
SCHEMBL11739337 0.76 ATM (0.70) ATML3MBTL1TDP1ACHEKMT2A
SCHEMBL21939660 0.73 CYP1A2 (0.46) L3MBTL1KMT2AALDH1A1KDM4EMEN1
SCHEMBL10587995 0.72 ALDH1A1 (0.52) ATML3MBTL1TDP1ACHEKMT2A
SCHEMBL30762501 0.72 KMT2A (0.57) ATML3MBTL1TDP1ACHEKMT2A
SCHEMBL11863517 0.72 ALDH1A1 (0.52) ATML3MBTL1TDP1ACHEKMT2A
SCHEMBL17531151 0.71 L3MBTL1 (0.71) ATML3MBTL1TDP1ACHEKMT2A
SCHEMBL14595182 0.71 ALDH1A1 (0.65) KMT2AMAPK1ALDH1A1KDM4EMEN1
SCHEMBL30762379 0.70 ALDH1A1 (0.48) ATMKMT2APOLBMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026423-A1 SUBSTITUTED QUINOLINE DERIVATIVES AS PI3K INHIBITORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback